Literature DB >> 31178124

Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms.

Aurélie Crabbé1, Peter Østrup Jensen2, Thomas Bjarnsholt3, Tom Coenye4.   

Abstract

Active bacterial metabolism is a prerequisite for optimal activity of many classes of antibiotics. Hence, bacteria have developed strategies to reduce or modulate metabolic pathways to become tolerant. This review describes the tight relationship between metabolism and tolerance in bacterial biofilms, and how physicochemical properties of the microenvironment at the host-pathogen interface (such as oxygen and nutritional content) are key to this relationship. Understanding how metabolic adaptations lead to tolerance brings us to novel approaches to tackle antibiotic-tolerant biofilms. We describe the use of hyperbaric oxygen therapy, metabolism-stimulating metabolites, and alternative strategies to redirect bacterial metabolism towards an antibiotic-susceptible phenotype.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antimicrobial tolerance; biofilm; metabolism

Mesh:

Substances:

Year:  2019        PMID: 31178124     DOI: 10.1016/j.tim.2019.05.003

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  56 in total

Review 1.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

2.  Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.

Authors:  Catherine R Armbruster; Tom Coenye; Lhousseine Touqui; Jennifer M Bomberger
Journal:  J Cyst Fibros       Date:  2019-11-02       Impact factor: 5.482

Review 3.  Biology of antimicrobial resistance and approaches to combat it.

Authors:  Sarah M Schrader; Julien Vaubourgeix; Carl Nathan
Journal:  Sci Transl Med       Date:  2020-06-24       Impact factor: 17.956

4.  Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.

Authors:  Marwa N Ahmed; Andreas Porse; Ahmed Abdelsamad; Morten Sommer; Niels Høiby; Oana Ciofu
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

5.  Synergistic Effect of Biogenics Derived from Potential Probiotics Together with Zingerone Against Biofilm Formation by Pseudomonas aeruginosa PAO1.

Authors:  Swati Chandla; Kusum Harjai; Geeta Shukla
Journal:  Probiotics Antimicrob Proteins       Date:  2021-03-30       Impact factor: 4.609

Review 6.  Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.

Authors:  Elio Rossi; Ruggero La Rosa; Jennifer A Bartell; Rasmus L Marvig; Janus A J Haagensen; Lea M Sommer; Søren Molin; Helle Krogh Johansen
Journal:  Nat Rev Microbiol       Date:  2020-11-19       Impact factor: 60.633

7.  Potentiation of Aminoglycoside Lethality by C4-Dicarboxylates Requires RpoN in Antibiotic-Tolerant Pseudomonas aeruginosa.

Authors:  Clayton W Hall; Eszter Farkas; Li Zhang; Thien-Fah Mah
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 8.  Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.

Authors:  Amjed Alabresm; Savannah L Chandler; Brian C Benicewicz; Alan W Decho
Journal:  Bioconjug Chem       Date:  2021-07-28       Impact factor: 4.774

9.  The Quorum-Sensing Inhibitor Furanone C-30 Rapidly Loses Its Tobramycin-Potentiating Activity against Pseudomonas aeruginosa Biofilms during Experimental Evolution.

Authors:  Mona Bové; Xuerui Bao; Andrea Sass; Aurélie Crabbé; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

Review 10.  Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy.

Authors:  Runqi Zhu; Tianqun Lang; Wenlu Yan; Xiao Zhu; Xin Huang; Qi Yin; Yaping Li
Journal:  Adv Sci (Weinh)       Date:  2021-03-09       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.